ヘルスケアCROの世界市場 (2021年～2028年)：産業分析・規模・シェア・成長・動向・予測

当レポートでは、世界のヘルスケアCROの市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 仮定・調査手法

第3章 エグゼクティブサマリー：世界のヘルスケアCRO市場

第4章 市場概要

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 世界市場の分析・予測
  • 市場収益予測
  • 出荷数量予測
• ポーターのファイブフォース分析

第5章 重要洞察

• 主要なM&A
• 規制シナリオ：世界・地域別
• COVID-19：影響分析

第6章 世界のヘルスケアCRO市場の分析・予測：サービス別

• イントロダクション・定義
• 主な調査結果・展開
• 市場予測：金額・数量
  • 臨床試験サービス
  • 規制サービス
  • 臨床データ管理・バイオメトリクス
  • メディカルライティング
  • ファーマコビジランス
  • サイト管理プロトコル
  • その他
• 市場の魅力

第7章 世界のヘルスケアCRO市場の分析・予測：エンドユーザー別

• イントロダクション・定義
• 主な調査結果・展開
• 市場予測：金額・数量
  • 製薬企業
  • バイオテクノロジー企業
  • 医療機器
  • 学術機関・政府機関
• 市場の魅力

第8章 世界のヘルスケアCRO市場の分析・予測：治療分野別

• イントロダクション・定義
• 主な調査結果・展開
• 市場予測：金額・数量
  • 腫瘍/血液
  • CNS
  • CV/代謝
  • 呼吸器
  • 感染症
  • 免疫
  • 希少疾患
  • 医療機器
  • その他
• 市場の魅力

第9章 世界のヘルスケアCRO市場の分析・予測：地域別

• 主な調査結果
• 市場予測：金額・数量
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 市場の魅力

第10章 北米のヘルスケアCRO市場の分析・予測

第11章 欧州のヘルスケアCRO市場の分析・予測

第12章 アジア太平洋のヘルスケアCRO市場の分析・予測

第13章 ラテンアメリカのヘルスケアCRO市場の分析・予測

第14章 中東およびアフリカのヘルスケアCRO市場の分析・予測

第15章 競合情勢

• 参入事業者：競合マトリックス（企業ティア・規模別）
• 市場シェア分析：企業別
• 企業プロファイル
  • Syneos Health
  • PAREXEL International
  • ICON plc
  • PRA Health Sciences, Inc.
  • Charles River
  • Laboratory Corporation of America Holdings(Covance)
  • IQVIA
  • Medpace
  • Pharmaceutical Product Development, LLC.

List of Table

• Table 01: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017-2028
• Table 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017-2028
• Table 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017-2028
• Table 04: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017-2028
• Table 05: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017-2028
• Table 06: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Region, 2017-2028
• Table 07: North America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country, 2017-2028
• Table 08: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017-2028
• Table 09: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Service, 2017-2028
• Table 10: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017-2028
• Table 11: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017-2028
• Table 12: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017-2028
• Table 13: Europe Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2028
• Table 14: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Services, 2017-2028
• Table 15: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017-2028
• Table 16: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017-2028
• Table 17: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017-2028
• Table 18: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017-2028
• Table 19: Asia Pacific Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
• Table 20: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017-2028
• Table 21: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017-2028
• Table 22: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017-2028
• Table 23: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017-2028
• Table 24: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017-2028
• Table 25: Latin America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
• Table 26: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017-2028
• Table 27: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017-2028
• Table 28: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017-2028
• Table 29: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017-2028
• Table 30: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017-2028
• Table 31: Middle East & Africa Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
• Table 32: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017-2028
• Table 33: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017-2028
• Table 34: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017-2028
• Table 35: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017-2028
• Table 36: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017-2028

List of Figures

• Figure 01: Healthcare Contract Research Outsourcing Market Snapshot
• Figure 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017-2028
• Figure 03: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020
• Figure 04: Global Healthcare Contract Research Outsourcing Market Value Share, by Region, 2020
• Figure 05: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020
• Figure 06: Global Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020
• Figure 07: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2028
• Figure 08: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Trial Services, 2017-2028
• Figure 09: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Regulatory Services, 2017-2028
• Figure 10: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Data Management & Biometrics, 2017-2028
• Figure 11: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Writing, 2017-2028
• Figure 12: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmacovigilance, 2017-2028
• Figure 13: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Site Management Protocol, 2017-2028
• Figure 14: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service
• Figure 15: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2017 and 2028
• Figure 16: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Oncology, 2017-2028
• Figure 17: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CNS, 2017-2028
• Figure 18: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CV/Metabolic, 2017-2028
• Figure 19: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Respiratory, 2017-2028
• Figure 20: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2017-2028
• Figure 21: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Immunology, 2017-2028
• Figure 22: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Rare Diseases, 2017-2028
• Figure 23: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Devices, 2017-2028
• Figure 24: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area
• Figure 25: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by End-user, 2017 and 2028
• Figure 26: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017-2028
• Figure 27: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Biotechnology Companies, 2017-2028
• Figure 28: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Device Companies, 2017-2028
• Figure 29: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Academic Institute & Government Organizations Companies, 2017-2028
• Figure 30: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021-2028
• Figure 31: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by Region, 2021 and 2028
• Figure 32: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Region, 2021-2028
• Figure 33: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017-2028
• Figure 34: North America Healthcare Contract Research Outsourcing Market Value Share, by Country, 2020 and 2028
• Figure 35: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country, 2021-2020
• Figure 36: North America Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028
• Figure 37: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2020-1028
• Figure 38: North America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028
• Figure 39: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
• Figure 40: North America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
• Figure 41: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021-2028
• Figure 42: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2021-2028
• Figure 43: Europe Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
• Figure 44: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
• Figure 45: Europe Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028
• Figure 46: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2021-2028
• Figure 47: Europe Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020 and 2028
• Figure 48: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
• Figure 49: Europe Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
• Figure 50: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021-2028
• Figure 51: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017-2028
• Figure 52: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
• Figure 53: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
• Figure 54: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028
• Figure 55: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028
• Figure 56: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028
• Figure 57: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
• Figure 58: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
• Figure 59: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021-2028
• Figure 60: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017-2028
• Figure 61: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020 and 2028
• Figure 62: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028
• Figure 63: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area 2020 and 2028
• Figure 64: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
• Figure 65: Latin America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
• Figure 66: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021-2028
• Figure 67: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
• Figure 68: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
• Figure 69: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017-2028
• Figure 70: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
• Figure 71: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
• Figure 72: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028
• Figure 73: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028
• Figure 74: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028
• Figure 75: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
• Figure 76: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
• Figure 77: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021-2028
• Figure 78: Global Healthcare Contract Research Outsourcing Market Share Analysis, by Company, 2020

Healthcare Contract Research Outsourcing Market - Scope of Report

TMR's report on the global healthcare contract research outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global healthcare contract research outsourcing market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global healthcare contract research outsourcing market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the healthcare contract research outsourcing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global healthcare contract research outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global healthcare contract research outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global healthcare contract research outsourcing market.

The report delves into the competitive landscape of the global healthcare contract research outsourcing market. Key players operating in the global healthcare contract research outsourcing market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global healthcare contract research outsourcing market profiled in this report.

Key Questions Answered in Healthcare Contract Research Outsourcing Market Report

What will be the sales/revenue generated by healthcare contract research outsourcing across all the geographies during the forecast period?

What are the key trends in the healthcare contract research outsourcing market?

What are the major drivers, restraints, and opportunities in the market?

Which region is set to grow at the highest CAGR during the forecast period?

Which segment will have the highest revenue globally in 2028 and which services segment will grow at the highest CAGR during the forecast period?

Healthcare Contract Research Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global healthcare contract research outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global healthcare contract research outsourcing market in terms of service, therapeutic area, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global healthcare contract research outsourcing market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Healthcare Contract Research Outsourcing Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Service Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, 2017-2028
  • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.4.2. Market Volume/Unit Shipments Projections
• 4.5. Porter's Five Force Analysis

5. Key Insights

• 5.1. Key Mergers & Acquisitions
• 5.2. Regulatory Scenario by Region/globally
• 5.3. COVID-19 Impact Analysis

6. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Service

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value & Volume Forecast, by Service, 2017-2028
  • 6.3.1. Clinical Trial Services
  • 6.3.2. Regulatory Services
  • 6.3.3. Clinical Data Management & Biometrics
  • 6.3.4. Medical Writing
  • 6.3.5. Pharmacovigilance
  • 6.3.6. Site Management Protocol
  • 6.3.7. Others
• 6.4. Market Attractiveness Analysis, by Service

7. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by End-user

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value & Volume Forecast, by End-user, 2017-2028
  • 7.3.1. Pharmaceutical Companies
  • 7.3.2. Biotechnology Companies
  • 7.3.3. Medical Devices
  • 7.3.4. Academic Institutes & Government Organizations
• 7.4. Market Attractiveness Analysis, by End-user

8. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Therapeutic Area

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
  • 8.3.1. Oncology/Hematology
  • 8.3.2. CNS
  • 8.3.3. CV/Metabolic
  • 8.3.4. Respiratory
  • 8.3.5. Infectious Diseases
  • 8.3.6. Immunology
  • 8.3.7. Rare Diseases
  • 8.3.8. Medical Devices
  • 8.3.9. Others
• 8.4. Market Attractiveness Analysis, by Therapeutic Area

9. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value & Volume Forecast, by Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Healthcare Contract Research Outsourcing Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value & Volume Forecast, by Service, 2017-2028
  • 10.2.1. Clinical Trial Services
  • 10.2.2. Regulatory Services
  • 10.2.3. Clinical Data Management & Biometrics
  • 10.2.4. Medical Writing
  • 10.2.5. Pharmacovigilance
  • 10.2.6. Site Management Protocol
  • 10.2.7. Others
• 10.3. Market Value & Volume Forecast, by End-user, 2017-2028
  • 10.3.1. Pharmaceutical Companies
  • 10.3.2. Biotechnology Companies
  • 10.3.3. Medical Devices
  • 10.3.4. Academic Institutes & Government Organizations
• 10.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
  • 10.4.1. Oncology/Hematology
  • 10.4.2. CNS
  • 10.4.3. CV/Metabolic
  • 10.4.4. Respiratory
  • 10.4.5. Infectious Diseases
  • 10.4.6. Immunology
  • 10.4.7. Rare Diseases
  • 10.4.8. Medical Devices
  • 10.4.9. Others
• 10.5. Market Value & Volume Forecast, by Country, 2017-2028
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Service
  • 10.6.2. By End-user
  • 10.6.3. By Therapeutic Area
  • 10.6.4. By Country

11. Europe Healthcare Contract Research Outsourcing Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value & Volume Forecast, by Service, 2017-2028
  • 11.2.1. Clinical Trial Services
  • 11.2.2. Regulatory Services
  • 11.2.3. Clinical Data Management & Biometrics
  • 11.2.4. Medical Writing
  • 11.2.5. Pharmacovigilance
  • 11.2.6. Site Management Protocol
  • 11.2.7. Others
• 11.3. Market Value & Volume Forecast, by End-user, 2017-2028
  • 11.3.1. Pharmaceutical Companies
  • 11.3.2. Biotechnology Companies
  • 11.3.3. Medical Devices
  • 11.3.4. Academic Institutes & Government Organizations
• 11.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
  • 11.4.1. Oncology/Hematology
  • 11.4.2. CNS
  • 11.4.3. CV/Metabolic
  • 11.4.4. Respiratory
  • 11.4.5. Infectious Diseases
  • 11.4.6. Immunology
  • 11.4.7. Rare Diseases
  • 11.4.8. Medical Devices
  • 11.4.9. Others
• 11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Service
  • 11.6.2. By End-user
  • 11.6.3. By Therapeutic Area
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Healthcare Contract Research Outsourcing Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value & Volume Forecast, by Service, 2017-2028
  • 12.2.1. Clinical Trial Services
  • 12.2.2. Regulatory Services
  • 12.2.3. Clinical Data Management & Biometrics
  • 12.2.4. Medical Writing
  • 12.2.5. Pharmacovigilance
  • 12.2.6. Site Management Protocol
  • 12.2.7. Others
• 12.3. Market Value & Volume Forecast, by End-user, 2017-2028
  • 12.3.1. Pharmaceutical Companies
  • 12.3.2. Biotechnology Companies
  • 12.3.3. Medical Devices
  • 12.3.4. Academic Institutes & Government Organizations
• 12.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
  • 12.4.1. Oncology/Hematology
  • 12.4.2. CNS
  • 12.4.3. CV/Metabolic
  • 12.4.4. Respiratory
  • 12.4.5. Infectious Diseases
  • 12.4.6. Immunology
  • 12.4.7. Rare Diseases
  • 12.4.8. Medical Devices
  • 12.4.9. Others
• 12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Service
  • 12.6.2. By End-user
  • 12.6.3. By Therapeutic Area
  • 12.6.4. By Country/Sub-region

13. Latin America Healthcare Contract Research Outsourcing Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value & Volume Forecast, by Service, 2017-2028
  • 13.2.1. Clinical Trial Services
  • 13.2.2. Regulatory Services
  • 13.2.3. Clinical Data Management & Biometrics
  • 13.2.4. Medical Writing
  • 13.2.5. Pharmacovigilance
  • 13.2.6. Site Management Protocol
  • 13.2.7. Others
• 13.3. Market Value & Volume Forecast, by End-user, 2017-2028
  • 13.3.1. Pharmaceutical Companies
  • 13.3.2. Biotechnology Companies
  • 13.3.3. Medical Devices
  • 13.3.4. Academic Institutes & Government Organizations
• 13.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
  • 13.4.1. Oncology/Hematology
  • 13.4.2. CNS
  • 13.4.3. CV/Metabolic
  • 13.4.4. Respiratory
  • 13.4.5. Infectious Diseases
  • 13.4.6. Immunology
  • 13.4.7. Rare Diseases
  • 13.4.8. Medical Devices
  • 13.4.9. Others
• 13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Service
  • 13.6.2. By End-user
  • 13.6.3. By Therapeutic Area
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Healthcare Contract Research Outsourcing Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value & Volume Forecast, by Service, 2017-2028
  • 14.2.1. Clinical Trial Services
  • 14.2.2. Regulatory Services
  • 14.2.3. Clinical Data Management & Biometrics
  • 14.2.4. Medical Writing
  • 14.2.5. Pharmacovigilance
  • 14.2.6. Site Management Protocol
  • 14.2.7. Others
• 14.3. Market Value & Volume Forecast, by End-user, 2017-2028
  • 14.3.1. Pharmaceutical Companies
  • 14.3.2. Biotechnology Companies
  • 14.3.3. Medical Devices
  • 14.3.4. Academic Institutes & Government Organizations
• 14.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
  • 14.4.1. Oncology/Hematology
  • 14.4.2. CNS
  • 14.4.3. CV/Metabolic
  • 14.4.4. Respiratory
  • 14.4.5. Infectious Diseases
  • 14.4.6. Immunology
  • 14.4.7. Rare Diseases
  • 14.4.8. Medical Devices
  • 14.4.9. Others
• 14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Service
  • 14.6.2. By End-user
  • 14.6.3. By Therapeutic Area
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (by tier and size of companies)
• 15.2. Market Share Analysis, by Company, 2020
• 15.3. Company Profiles
  • 15.3.1. Syneos Health
    • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.1.2. Product Portfolio
    • 15.3.1.3. SWOT Analysis
    • 15.3.1.4. Strategic Overview
  • 15.3.2. PAREXEL International
    • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.2.2. Product Portfolio
    • 15.3.2.3. SWOT Analysis
    • 15.3.2.4. Strategic Overview
  • 15.3.3. ICON plc
    • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.3.2. Product Portfolio
    • 15.3.3.3. SWOT Analysis
    • 15.3.3.4. Strategic Overview
  • 15.3.4. PRA Health Sciences, Inc.
    • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.4.2. Product Portfolio
    • 15.3.4.3. SWOT Analysis
    • 15.3.4.4. Strategic Overview
  • 15.3.5. Charles River
    • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.5.2. Product Portfolio
    • 15.3.5.3. SWOT Analysis
    • 15.3.5.4. Strategic Overview
  • 15.3.6. Laboratory Corporation of America Holdings (Covance)
    • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.6.2. Product Portfolio
    • 15.3.6.3. SWOT Analysis
    • 15.3.6.4. Strategic Overview
  • 15.3.7. IQVIA
    • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.7.2. Product Portfolio
    • 15.3.7.3. SWOT Analysis
    • 15.3.7.4. Strategic Overview
  • 15.3.8. Medpace
    • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.8.2. Product Portfolio
    • 15.3.8.3. SWOT Analysis
    • 15.3.8.4. Strategic Overview
  • 15.3.9. Pharmaceutical Product Development, LLC.
    • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.9.2. Product Portfolio
    • 15.3.9.3. SWOT Analysis
    • 15.3.9.4. Strategic Overview